Hadrien Mendonca
With the midcaps making a comeback, Sanofi India has gained further strength. The stock has not only moved higher but has also broken out from a three-month consolidation phase.
Maintaining its higher top higher bottom structure, relative strength too indicates stock has a potential of making a dash towards its potential target of Rs 5,707 in the medium term.
Disclaimer: The author is Senior Technical Analyst, IIFL. The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
